Coleman E. Johnson
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- Immune Cell Function and Interaction 1
- Oncology 1
- CAR-T cell therapy research 1
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Kristian Michael Hargadon (3 shared papers)Corey J. Williams (3 shared papers)Balázs Győrffy (1 shared paper)
- Journals
- Cancer Genomics & Proteomics (1 paper)International Immunopharmacology (1 paper)Methods in molecular biology (1 paper)
- Partner nations
- United StatesHungary
In The Last Decade
Coleman E. Johnson
3 papers receiving 988 citations
Coleman E. Johnson's Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 624
- Immunology 414
- Pulmonary and Respiratory Medicine 121
- Cancer Research 54
- Genetics 35
Countries citing papers authored by Coleman E. Johnson
This map shows the geographic impact of Coleman E. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Coleman E. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Coleman E. Johnson more than expected).
Fields of papers citing papers by Coleman E. Johnson
This network shows the impact of papers produced by Coleman E. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Coleman E. Johnson. The network helps show where Coleman E. Johnson may publish in the future.
Co-authors
The 3 scholars most cited alongside Coleman E. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors Hit paper breakdown → | 2018 | 986 |
| 2 | 2019 | 14 | |
| 3 | 2021 | 1 |
About Coleman E. Johnson
Coleman E. Johnson is a scholar working on Immunology, Oncology, Genetics, Molecular Biology and Insect Science, having authored 3 papers that have together received 1.0k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (1 paper), Virus-based gene therapy research (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), CAR-T cell therapy research (1 paper), FOXO transcription factor regulation (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Immune Cell Function and Interaction (1 paper). The work is most often cited by research in Oncology (624 citations), Immunology (414 citations), Pulmonary and Respiratory Medicine (121 citations), Cancer Research (54 citations) and Genetics (35 citations). Coleman E. Johnson has collaborated with scholars based in United States and Hungary. Frequent co-authors include Kristian Michael Hargadon, Corey J. Williams and Balázs Győrffy. Their work appears in journals such as Cancer Genomics & Proteomics, International Immunopharmacology and Methods in molecular biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.